Related references
Note: Only part of the references are listed.Prognostic and Therapeutic Impact of Argininosuccinate Synthetase 1 Control in Bladder Cancer as Monitored Longitudinally by PET Imaging
Michael D. Allen et al.
CANCER RESEARCH (2014)
Single Amino Acid Arginine Deprivation Triggers Prosurvival Autophagic Response in Ovarian Carcinoma SKOV3
Galyna Shuvayeva et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Three-dimensional environment renders cancer cells profoundly less susceptible to a single amino acid starvation
Bozhena Vynnytska-Myronovska et al.
AMINO ACIDS (2013)
L-Arginine Assay with the Use of Arginase I
N. E. Stasyuk et al.
APPLIED BIOCHEMISTRY AND MICROBIOLOGY (2013)
ASS1 as a Novel Tumor Suppressor Gene in Myxofibrosarcomas: Aberrant Loss via Epigenetic DNA Methylation Confers Aggressive Phenotypes, Negative Prognostic Impact, and Therapeutic Relevance
Hsuan-Ying Huang et al.
CLINICAL CANCER RESEARCH (2013)
Agmatine: clinical applications after 100 years in translation
John E. Piletz et al.
DRUG DISCOVERY TODAY (2013)
Improved method for expression and isolation of the Mycoplasma hominis arginine deiminase from the recombinant strain of Escherichia coli
Lyubov R. Fayura et al.
JOURNAL OF BIOTECHNOLOGY (2013)
Targeting Arginine-Dependent Cancers with Arginine-Degrading Enzymes: Opportunities and Challenges
Melissa M. Phillips et al.
CANCER RESEARCH AND TREATMENT (2013)
Bi-enzyme L-arginine-selective amperometric biosensor based on ammonium-sensing polyaniline-modified electrode
Nataliya Stasyuk et al.
BIOSENSORS & BIOELECTRONICS (2012)
Single amino acid arginine starvation efficiently sensitizes cancer cells to canavanine treatment and irradiation
Bozhena Vynnytska-Myronovska et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Strategies for optimizing the serum persistence of engineered human arginase I for cancer therapy
Everett Stone et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Overexpression of (His)(6)-tagged human arginase I in Saccharomyces cerevisiae and enzyme purification using metal affinity chromatography
Andriy E. Zakalskiy et al.
PROTEIN EXPRESSION AND PURIFICATION (2012)
Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis
B. Delage et al.
CELL DEATH & DISEASE (2012)
Canavanine augments proapoptotic effects of arginine deprivation in cultured human cancer cells
Bozhena O. Vynnytska et al.
ANTI-CANCER DRUGS (2011)
Replacing Mn2+ with Co2+ in Human Arginase I Enhances Cytotoxicity toward L-Arginine Auxotrophic Cancer Cell Lines
Everett M. Stone et al.
ACS CHEMICAL BIOLOGY (2010)
Cancer cell sensitivity to arginine deprivation in vitro is not determined by endogenous levels of arginine metabolic enzymes
Yaroslav P. Bobak et al.
CELL BIOLOGY INTERNATIONAL (2010)
Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes
Macus Tien Kuo et al.
ONCOTARGET (2010)
Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC)
Sam-Mui Tsui et al.
CANCER CELL INTERNATIONAL (2009)
Arginine Deiminase as a Novel Therapy for Prostate Cancer Induces Autophagy and Caspase-Independent Apoptosis
Randie H. Kim et al.
CANCER RESEARCH (2009)
Arginine deprivation as a targeted therapy for cancer
L. Feun et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion
Paul Ning-Man Cheng et al.
CANCER RESEARCH (2007)
Integrity and stability of the citrulline-arginine pathway in normal and tumour cell lines
DN Wheatley et al.
CANCER LETTERS (2005)
Controlling cancer by restricting arginine availability - arginine-catabolizing enzymes as anticancer
DN Wheatley
ANTI-CANCER DRUGS (2004)